CN1170579C - Method for preparing - Google Patents
Method for preparing Download PDFInfo
- Publication number
- CN1170579C CN1170579C CNB02134096XA CN02134096A CN1170579C CN 1170579 C CN1170579 C CN 1170579C CN B02134096X A CNB02134096X A CN B02134096XA CN 02134096 A CN02134096 A CN 02134096A CN 1170579 C CN1170579 C CN 1170579C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- parts
- radices
- rhei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 239000008517 radix Trichosanthis Substances 0.000 claims description 7
- 206010061218 Inflammation Diseases 0.000 claims description 6
- 230000004054 inflammatory process Effects 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 239000002775 capsule Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000146029 Lindera aggregata Species 0.000 abstract 1
- 241000208167 Oxalis Species 0.000 abstract 1
- 235000008098 Oxalis acetosella Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a method for preparing a Fuyanxia capsule medicine, which adopts 7 kinds of traditional Chinese medicines of wood sorrel, patrinia, snakegourd root, radices rhei, radices rhei, cortex moutan radices, atractylodes rhizome and lindera root as raw materials. One half amounts of radices rhei is ground into fine powder, and the rest raw materials are decocted twice with water; filtered solution is obtained through filtering and merging, and the filtered solution is concentrated to be extracted with a relative density of 1.12 to 1.20; then the radices rhei fine powder are added into the extract, a granular or powdery medicine is prepared in a mode that the radices rhei fine powder and the extract are uniform mixed, dried and pulverized, and a finished product is obtained by that the medicine is encapsulated according to a conventional dose. The present invention has the functions of clearing heat, removing toxin, promoting vital energy, removing blood stasis, eliminating dampness and arresting leucorrhea, and has the advantages of good curative effect, rapid effect, low treatment expense, no toxic and side effect, and safe taking.
Description
Technical field:
The present invention relates to a kind of manufacture method for the treatment of the FUYANXIAO JIAONANG medicine of disease under inflammation of woman genetic system, the TONGJINGDAI.
Background technology:
At present, the medicine for the treatment of disease under inflammation of woman genetic system, the TONGJINGDAI in the prior art generally all adopts Western medicine, though these Western medicine all have certain therapeutic effect, but ubiquity certain toxic and side effects and is existed complex manufacturing technology, shortcoming that cost is high, and these Western medicine in use, therefore must under doctor's guidance, just can take, still safety inadequately in clinical use.
Summary of the invention:
The objective of the invention is: a kind of disease under inflammation of woman genetic system, the TONGJINGDAI of can treating is provided, and have no side effect, good effect, the manufacture method of taking the FUYANXIAO JIAONANG medicine of comparison safety, overcoming the deficiency of existing medicine.
The present invention is achieved in that its employing Herba Oxalidis Corniculatae, Herba Patriniae, Radix Trichosanthis, Radix Et Rhizoma Rhei, Cortex Moutan, Rhizoma Atractylodis, the Radix Linderae 7 flavor Chinese medicines are raw material, each raw material component by weight is respectively: 25～600 parts of Herba Oxalidis Corniculataes, 25～600 parts of Herba Patriniae, 25～500 parts of Radix Trichosanthis, 25～600 parts of Radix Et Rhizoma Rhei, 25～300 parts of Cortex Moutans, 25～500 parts of Rhizoma Atractylodis, 25～600 parts of the Radixs Linderae, the Radix Et Rhizoma Rhei of getting 1/2nd amounts is broken into fine powder, all the other raw materials decoct with water 2 times, boiled two hours at every turn, filtration merge filtrate, filtrate is concentrated into relative density under 60 ℃～70 ℃ temperature be 1.12～1.20 clear paste, in clear paste, add the Radix Et Rhizoma Rhei fine powder then, through mixing, dry, make graininess or powdery medicine after the pulverizing, this medicine is measured routinely promptly made FUYANXIAO JIAONANG medicine finished product after incapsulating.
Owing to adopted technique scheme, the medicine of disease is compared under the present invention and existing treatment inflammation of woman genetic system, the TONGJINGDAI, it is raw material that the present invention adopts Chinese herbal medicine fully, be Miao medicine formula, it has the function of heat-clearing and toxic substances removing, regulating qi to disperse stagnation, eliminating dampness and arresting leucorrhea, it not only has good effect, instant effect, advantage that medical expense is low, has no side effect, takes safe advantage but also have.
The specific embodiment:
Embodiments of the invention 1: get Herba Oxalidis Corniculatae, Herba Patriniae, Radix Trichosanthis, Radix Et Rhizoma Rhei, Cortex Moutan, Rhizoma Atractylodis, each 25 gram of the Radix Linderae seven flavor Chinese medicines, will be wherein the Radix Et Rhizoma Rhei of 1/2nd amounts to be broken into fine powder standby, all the other Chinese medicines are mixed decoct with water 2 times, boiled two hours at every turn, and get filtrate after filtering merging, this filtrate is concentrated into relative density under 60 ℃～70 ℃ temperature be 1.12～1.20 clear paste, in clear paste, add the Radix Et Rhizoma Rhei fine powder then, through mixing, dry, promptly make graininess or pulverous medicine after the pulverizing, promptly make FUYANXIAO JIAONANG medicine finished product after this medicine is incapsulated by every 0.45 amount that restrains.
Embodiments of the invention 2: get Herba Oxalidis Corniculatae, Herba Patriniae, Radix Et Rhizoma Rhei, each 600 gram of the Radix Linderae four flavor Chinese medicines, Cortex Moutan is Chinese medicine 300 grams simply, Rhizoma Atractylodis and each 500 gram of Radix Trichosanthis two flavor Chinese medicines, will be wherein the Radix Et Rhizoma Rhei of 1/2nd amounts to be broken into fine powder standby, all the other Chinese medicines are mixed decoct with water 2 times, boiled two hours at every turn, and get filtrate after filtering merging, this filtrate is concentrated into relative density under 60 ℃～70 ℃ temperature be 1.12～1.20 clear paste, in clear paste, add the Radix Et Rhizoma Rhei fine powder then, through mixing, dry, promptly make graininess or pulverous medicine after the pulverizing, promptly make FUYANXIAO JIAONANG medicine finished product after this medicine is incapsulated by every 0.45 amount that restrains.
Embodiments of the invention 3: get Herba Oxalidis Corniculatae, Herba Patriniae, Radix Et Rhizoma Rhei, each 300 gram of the Radix Linderae four flavor Chinese medicines, Cortex Moutan is Chinese medicine 150 grams simply, Rhizoma Atractylodis and each 250 gram of Radix Trichosanthis two flavor Chinese medicines, will be wherein the Radix Et Rhizoma Rhei of 1/2nd amounts to be broken into fine powder standby, all the other Chinese medicines are mixed decoct with water 2 times, boiled two hours at every turn, and get filtrate after filtering merging, this filtrate is concentrated into relative density under 60 ℃～70 ℃ temperature be 1.12～1.20 clear paste, in clear paste, add the Radix Et Rhizoma Rhei fine powder then, through mixing, dry, promptly make graininess or pulverous medicine after the pulverizing, promptly make FUYANXIAO JIAONANG medicine finished product after this medicine is incapsulated by every 0.45 amount that restrains.
More than the usage and the consumption of the capsule finished product medicine that makes of three embodiment be: oral, one time 2～3,3 times on the one.General two～all around is a course of treatment.
Claims (1)
1, the capsular method for making of a kind of treatment gynecological inflammation, it is characterized in that: it adopts Herba Oxalidis Corniculatae, Herba Patriniae, Radix Trichosanthis, Radix Et Rhizoma Rhei, Cortex Moutan, Rhizoma Atractylodis, the Radix Linderae 7 flavor Chinese medicines are raw material, each raw material component by weight is respectively: 25～600 parts of Herba Oxalidis Corniculataes, 25～600 parts of Herba Patriniae, 25～500 parts of Radix Trichosanthis, 25～600 parts of Radix Et Rhizoma Rhei, 25～300 parts of Cortex Moutans, 25～500 parts of Rhizoma Atractylodis, 25～600 parts of the Radixs Linderae, the Radix Et Rhizoma Rhei of getting 1/2nd amounts is broken into fine powder, all the other raw materials decoct with water 2 times, boiled two hours at every turn, filtration merge filtrate, filtrate is concentrated into relative density under 60 ℃～70 ℃ temperature be 1.12～1.20 clear paste, in clear paste, add the Radix Et Rhizoma Rhei fine powder then, through mixing, dry, make graininess or powdery medicine after the pulverizing, this medicine is measured routinely promptly made FUYANXIAO JIAONANG medicine finished product after incapsulating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB02134096XA CN1170579C (en) | 2002-11-15 | 2002-11-15 | Method for preparing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB02134096XA CN1170579C (en) | 2002-11-15 | 2002-11-15 | Method for preparing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1413694A CN1413694A (en) | 2003-04-30 |
| CN1170579C true CN1170579C (en) | 2004-10-13 |
Family
ID=4747558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB02134096XA Expired - Lifetime CN1170579C (en) | 2002-11-15 | 2002-11-15 | Method for preparing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1170579C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111714568B (en) * | 2019-10-24 | 2021-12-24 | 贵州益佰女子大药厂有限责任公司 | Preparation method of Fuyanxiao preparation |
-
2002
- 2002-11-15 CN CNB02134096XA patent/CN1170579C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1413694A (en) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108029821A (en) | Bark of eucommia solid health-care tea and preparation method thereof | |
| CN1415329A (en) | Compund paste of donkey-skin gelatin for enriching the blood | |
| CN102119979A (en) | Oral ulcer compound preparation | |
| CN104338044A (en) | Drug for treating gynecological abnormal leucorrhea and preparation method thereof | |
| CN1072860A (en) | The prescription of anti-encephalasthenia capsule and preparation technology | |
| CN103055193A (en) | Chinese medicinal composition for treating eczema | |
| CN101601835A (en) | Tumor post-operation treating medicine and preparation method thereof | |
| CN1049827C (en) | Anti-cancer powder | |
| CN100569263C (en) | A kind of pharmaceutical composition for the treatment of stomachache and preparation method thereof | |
| CN1170579C (en) | Method for preparing | |
| CN1056064C (en) | Medicine for curing liver cancer and its making method | |
| CN101966261A (en) | Medicament for treating high blood pressure and preparation method thereof | |
| CN103463415A (en) | Preparation method of traditional Chinese medicine for treating atrophic gastritis | |
| CN101264164A (en) | Medicinal composition for treating tumor and preparation thereof | |
| CN101816774A (en) | Medicinal powder for nourishing blood, regulating menstruation and removing maculae | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN1175879C (en) | Medicine for curing pain syndrome of late cancer and its preparation | |
| CN101637553A (en) | Chinese medicinal composition for treating hysteromyoma and preparation method thereof | |
| CN101264252A (en) | Chinese medicine for treating apositia of children and preparation thereof | |
| CN101317934B (en) | Chinese medicine for treating chronic sinusitis | |
| CN100363044C (en) | Medicine for treating acne and its preparation method | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation | |
| CN1062176C (en) | Oral liquid for curing cancer | |
| CN108175841A (en) | Chinese medicine preparation of gastritis, gastric ulcer and preparation method thereof to the ill | |
| CN1168484C (en) | Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: GUIZHOU BAIXIANG PHARMACEUTICAL CO. Free format text: FORMER NAME OR ADDRESS: GUIZHOU QIKAI PHARMACEUTICAL CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: 550001, A-12 building, Zhicheng building, 1 East Yanan Road, Guiyang, Guizhou Patentee after: Guizhou Baixiang Pharmaceutical Co.,Ltd. Address before: 550001, A-12 building, Zhicheng building, 1 East Yanan Road, Guiyang, Guizhou Patentee before: GUIZHOU QIKAI PHARMACEUTICAL Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20081224 Pledge (preservation): Pledge |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100127 Pledge (preservation): Pledge registration |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20100127 Pledge (preservation): Pledge |
|
| DD01 | Delivery of document by public notice |
Addressee: Guizhou Baixiang Pharmaceutical Co.,Ltd. Document name: Notification that Application Deemed not to be Proposed |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20110523 Granted publication date: 20041013 Pledgee: Guiyang City Commercial Bank Hing Building Branch Pledgor: Guizhou Baixiang Pharmaceutical Co.,Ltd. Registration number: 2010520000687 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| C56 | Change in the name or address of the patentee | ||
| CP03 | Change of name, title or address |
Address after: 550002, No. 5 Yinhua Road, Nanming District, Guizhou, Guiyang Patentee after: GUIZHOU YIBAI WOMAN BIG PHARMACEUTICAL FACTORY Address before: 550001, A-12 building, Zhicheng building, 1 East Yanan Road, Guiyang, Guizhou Patentee before: Guizhou Baixiang Pharmaceutical Co.,Ltd. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20041013 |